Turkey Pharmaceutical Market Report by Type (Pharmaceutical Drugs, Biologics), Nature (Organic, Conventional), and Region 2026-2034
The Turkey pharmaceutical market size reached USD 22.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 32.6 Billion by 2034, exhibiting a growth rate (CAGR) of 4.19% during 2026-2034 . The market is primarily driven by the expanding healthcare sector due to easy access to healthcare services, rising demand among the growing geriatric population, advancements in medical technology, and strategic investments by local and international pharmaceutical companies across the region.
Turkey Pharmaceutical Market Trends:
THE GROWING AGING POPULATION:
The demographic patterns in Turkey including population growth and an aging population, are influencing the pharmaceutical industry in Turkey. According to the Turkish Statistical Institute press release stating that 6,895,385 people were 65 years of age or older in 2017. This group increased by 22.6% during the next five years, to reach 8,451,669 individuals by 2022. The percentage of the population that is old grew throughout this time, rising from 8.5% in 2017 to 9.9% in 2022. In 2022, there were 44.4% men and 55.6% women among the old population. Moreover, the population forecasts indicate that the percentage of old people will likely continue to rise, reaching 12.9% by 2030, 16.3% by 2040, 22.6% by 2060, and 25.6% by 2080. These projections are escalating the demand for pharmaceutical products tailored to chronic disease management, geriatric care, and the overall healthcare needs of the geriatric population. This demographic shift has prompted pharmaceutical companies to innovate and develop medications that address age-related conditions such as cardiovascular diseases, diabetes, and arthritis.
INCREASED ACCESS TO HEALTHCARE:
The Turkish pharmaceutical industry has been greatly influenced by the growth of healthcare services. According to ilac Endustrisi iseverenler Sendikasi (IEIS), pharmaceutical manufacturer of Turkiye, the value of Turkey's combined pharmaceutical and healthcare product market including sales from pharmacies and hospitals increased to TRY 121.6 billion in 2022, a noteworthy 78.8% growth. The market increased by 8.6% in terms of unit sales, reaching 2.82 Billion units. Additionally, a variety of products authorized by the Ministry of Health are available in the healthcare market, including prescription drugs, foods specifically designed for health, and conventional herbal remedies. Moreover, the expansion was further aided by goods that were authorized by the Ministry of Agriculture and Forestry, including food supplements, vitamins, and formulae, thus contributing to the market growth. According to the most current statistics available, the healthcare market had a 7.1% increase in units and a 28.8% increase in value in 2021, demonstrating strong expansion across several industry areas. Hence, there the easy availability of pharmaceuticals is increasing the need for pharmaceutical items, ranging from specialty drugs to basic therapies across Turkey.
Turkey Pharmaceutical Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on type and nature.
TYPE INSIGHTS:
NATURE INSIGHTS:
REGIONAL INSIGHTS:
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Turkey pharmaceutical market performed so far and how will it perform in the coming years?
What is the breakup of the Turkey pharmaceutical market on the basis of type?
What is the breakup of the Turkey pharmaceutical market on the basis of nature?
What are the various stages in the value chain of the Turkey pharmaceutical market?
What are the key driving factors and challenges in the Turkey pharmaceutical?
What is the structure of the Turkey pharmaceutical market and who are the key players?
What is the degree of competition in the Turkey pharmaceutical market?
Turkey Pharmaceutical Market Trends:
THE GROWING AGING POPULATION:
The demographic patterns in Turkey including population growth and an aging population, are influencing the pharmaceutical industry in Turkey. According to the Turkish Statistical Institute press release stating that 6,895,385 people were 65 years of age or older in 2017. This group increased by 22.6% during the next five years, to reach 8,451,669 individuals by 2022. The percentage of the population that is old grew throughout this time, rising from 8.5% in 2017 to 9.9% in 2022. In 2022, there were 44.4% men and 55.6% women among the old population. Moreover, the population forecasts indicate that the percentage of old people will likely continue to rise, reaching 12.9% by 2030, 16.3% by 2040, 22.6% by 2060, and 25.6% by 2080. These projections are escalating the demand for pharmaceutical products tailored to chronic disease management, geriatric care, and the overall healthcare needs of the geriatric population. This demographic shift has prompted pharmaceutical companies to innovate and develop medications that address age-related conditions such as cardiovascular diseases, diabetes, and arthritis.
INCREASED ACCESS TO HEALTHCARE:
The Turkish pharmaceutical industry has been greatly influenced by the growth of healthcare services. According to ilac Endustrisi iseverenler Sendikasi (IEIS), pharmaceutical manufacturer of Turkiye, the value of Turkey's combined pharmaceutical and healthcare product market including sales from pharmacies and hospitals increased to TRY 121.6 billion in 2022, a noteworthy 78.8% growth. The market increased by 8.6% in terms of unit sales, reaching 2.82 Billion units. Additionally, a variety of products authorized by the Ministry of Health are available in the healthcare market, including prescription drugs, foods specifically designed for health, and conventional herbal remedies. Moreover, the expansion was further aided by goods that were authorized by the Ministry of Agriculture and Forestry, including food supplements, vitamins, and formulae, thus contributing to the market growth. According to the most current statistics available, the healthcare market had a 7.1% increase in units and a 28.8% increase in value in 2021, demonstrating strong expansion across several industry areas. Hence, there the easy availability of pharmaceuticals is increasing the need for pharmaceutical items, ranging from specialty drugs to basic therapies across Turkey.
Turkey Pharmaceutical Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on type and nature.
TYPE INSIGHTS:
- Pharmaceutical Drugs
- Cardiovascular Drugs
- Dermatology Drugs
- Gastrointestinal Drugs
- Genito-Urinary Drugs
- Hematology Drugs
- Anti-Infective Drugs
- Metabolic Disorder Drugs
- Musculoskeletal Disorder Drugs
- Central Nervous System Drugs
- Oncology Drugs
- Ophthalmology Drugs
- Respiratory Diseases Drugs
- Biologics
- Monoclonal Antibodies (MAbS)
- Therapeutic Proteins
- Vaccines
NATURE INSIGHTS:
- Organic
- Conventional
REGIONAL INSIGHTS:
- Marmara
- Central Anatolia
- Mediterranean
- Aegean
- Southeastern Anatolia
- Blacksea
- Eastern Anatolia
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Turkey pharmaceutical market performed so far and how will it perform in the coming years?
What is the breakup of the Turkey pharmaceutical market on the basis of type?
What is the breakup of the Turkey pharmaceutical market on the basis of nature?
What are the various stages in the value chain of the Turkey pharmaceutical market?
What are the key driving factors and challenges in the Turkey pharmaceutical?
What is the structure of the Turkey pharmaceutical market and who are the key players?
What is the degree of competition in the Turkey pharmaceutical market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 TURKEY PHARMACEUTICAL MARKET – INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 TURKEY PHARMACEUTICAL MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 TURKEY PHARMACEUTICAL MARKET - BREAKUP BY TYPE
6.1 Pharmaceutical Drugs
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Cardiovascular Drugs
6.1.3.2 Dermatology Drugs
6.1.3.3 Gastrointestinal Drugs
6.1.3.4 Genito-Urinary Drugs
6.1.3.5 Hematology Drugs
6.1.3.6 Anti-Infective Drugs
6.1.3.7 Metabolic Disorder Drugs
6.1.3.8 Musculoskeletal Disorder Drugs
6.1.3.9 Central Nervous System Drugs
6.1.3.10 Oncology Drugs
6.1.3.11 Ophthalmology Drugs
6.1.3.12 Respiratory Diseases Drugs
6.1.4 Market Forecast (2026-2034)
6.1.5 Market Breakup by Nature
6.2 Biologics
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.2.4 Market Segmentation
6.2.4.1 Monoclonal Antibodies (MAbS)
6.2.4.2 Therapeutic Proteins
6.2.4.3 Vaccines
6.2.5 Market Breakup by Nature
6.3 Attractive Investment Proposition by Type
7 TURKEY PHARMACEUTICAL MARKET - BREAKUP BY NATURE
7.1 Organic
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.1.4 Market Breakup by Type
7.2 Conventional
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.2.4 Market Breakup by Type
7.3 Attractive Investment Proposition by Nature
8 TURKEY PHARMACEUTICAL MARKET – BREAKUP BY REGION
9.1 Marmara
8.1.1 Market Drivers
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Type
8.1.4 Market Breakup by Nature
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Central Anatolia
8.2.1 Market Drivers
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Type
8.2.4 Market Breakup by Nature
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Mediterranean
8.3.1 Market Drivers
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Type
8.3.4 Market Breakup by Nature
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Aegean
8.4.1 Market Drivers
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Type
8.4.4 Market Breakup by Nature
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Southeastern Anatolia
8.5.1 Market Drivers
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Breakup by Type
8.5.4 Market Breakup by Nature
8.5.5 Key Players
8.5.6 Market Forecast (2026-2034)
8.6 Blacksea
8.6.1 Market Drivers
8.6.2 Historical and Current Market Trends (2020-2025)
8.6.3 Market Breakup by Type
8.6.4 Market Breakup by Nature
8.6.5 Key Players
8.6.6 Market Forecast (2026-2034)
8.7 Eastern Anatolia
8.7.1 Market Drivers
8.7.2 Historical and Current Market Trends (2020-2025)
8.7.3 Market Breakup by Type
8.7.4 Market Breakup by Nature
8.7.5 Key Players
8.7.6 Market Forecast (2026-2034)
8.8 Attractive Investment Proposition by Region
9 MARKET DYNAMICS
9.1 Market Driving Factors
9.2 Market Restraining Factors
9.3 Market Opportunities
10 KEY TECHNOLOGICAL TRENDS & DEVELOPMENT
11 RECENT INDUSTRY NEWS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 VALUE CHAIN ANALYSIS
14 TURKEY PHARMACEUTICAL MARKET – COMPETITIVE LANDSCAPE
14.1 Overview
14.2 Market Structure
14.3 Market Share by Key Players
14.4 Market Player Positioning
14.5 Top Winning Strategies
14.6 Competitive Dashboard
14.7 Company Evaluation Quadrant
15 COMPETITIVE LANDSCAPE
15.1 Company A
15.1.1 Business Overview
15.1.2 Products Offered
15.1.3 Business Strategies
15.1.4 SWOT Analysis
15.1.5 Major News and Events
15.2 Company B
15.2.1 Business Overview
15.2.2 Products Offered
15.2.3 Business Strategies
15.2.4 SWOT Analysis
15.2.5 Major News and Events
15.3 Company C
15.3.1 Business Overview
15.3.2 Products Offered
15.3.3 Business Strategies
15.3.4 SWOT Analysis
15.3.5 Major News and Events
15.4 Company D
15.4.1 Business Overview
15.4.2 Products Offered
15.4.3 Business Strategies
15.4.4 SWOT Analysis
15.4.5 Major News and Events
15.5 Company E
15.5.1 Business Overview
15.5.2 Products Offered
15.5.3 Business Strategies
15.5.4 SWOT Analysis
15.5.5 Major News and Events
16 STRATEGIC RECOMMENDATIONS
17 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 TURKEY PHARMACEUTICAL MARKET – INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 TURKEY PHARMACEUTICAL MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 TURKEY PHARMACEUTICAL MARKET - BREAKUP BY TYPE
6.1 Pharmaceutical Drugs
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Cardiovascular Drugs
6.1.3.2 Dermatology Drugs
6.1.3.3 Gastrointestinal Drugs
6.1.3.4 Genito-Urinary Drugs
6.1.3.5 Hematology Drugs
6.1.3.6 Anti-Infective Drugs
6.1.3.7 Metabolic Disorder Drugs
6.1.3.8 Musculoskeletal Disorder Drugs
6.1.3.9 Central Nervous System Drugs
6.1.3.10 Oncology Drugs
6.1.3.11 Ophthalmology Drugs
6.1.3.12 Respiratory Diseases Drugs
6.1.4 Market Forecast (2026-2034)
6.1.5 Market Breakup by Nature
6.2 Biologics
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.2.4 Market Segmentation
6.2.4.1 Monoclonal Antibodies (MAbS)
6.2.4.2 Therapeutic Proteins
6.2.4.3 Vaccines
6.2.5 Market Breakup by Nature
6.3 Attractive Investment Proposition by Type
7 TURKEY PHARMACEUTICAL MARKET - BREAKUP BY NATURE
7.1 Organic
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.1.4 Market Breakup by Type
7.2 Conventional
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.2.4 Market Breakup by Type
7.3 Attractive Investment Proposition by Nature
8 TURKEY PHARMACEUTICAL MARKET – BREAKUP BY REGION
9.1 Marmara
8.1.1 Market Drivers
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Type
8.1.4 Market Breakup by Nature
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Central Anatolia
8.2.1 Market Drivers
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Type
8.2.4 Market Breakup by Nature
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Mediterranean
8.3.1 Market Drivers
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Type
8.3.4 Market Breakup by Nature
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Aegean
8.4.1 Market Drivers
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Type
8.4.4 Market Breakup by Nature
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Southeastern Anatolia
8.5.1 Market Drivers
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Breakup by Type
8.5.4 Market Breakup by Nature
8.5.5 Key Players
8.5.6 Market Forecast (2026-2034)
8.6 Blacksea
8.6.1 Market Drivers
8.6.2 Historical and Current Market Trends (2020-2025)
8.6.3 Market Breakup by Type
8.6.4 Market Breakup by Nature
8.6.5 Key Players
8.6.6 Market Forecast (2026-2034)
8.7 Eastern Anatolia
8.7.1 Market Drivers
8.7.2 Historical and Current Market Trends (2020-2025)
8.7.3 Market Breakup by Type
8.7.4 Market Breakup by Nature
8.7.5 Key Players
8.7.6 Market Forecast (2026-2034)
8.8 Attractive Investment Proposition by Region
9 MARKET DYNAMICS
9.1 Market Driving Factors
9.2 Market Restraining Factors
9.3 Market Opportunities
10 KEY TECHNOLOGICAL TRENDS & DEVELOPMENT
11 RECENT INDUSTRY NEWS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 VALUE CHAIN ANALYSIS
14 TURKEY PHARMACEUTICAL MARKET – COMPETITIVE LANDSCAPE
14.1 Overview
14.2 Market Structure
14.3 Market Share by Key Players
14.4 Market Player Positioning
14.5 Top Winning Strategies
14.6 Competitive Dashboard
14.7 Company Evaluation Quadrant
15 COMPETITIVE LANDSCAPE
15.1 Company A
15.1.1 Business Overview
15.1.2 Products Offered
15.1.3 Business Strategies
15.1.4 SWOT Analysis
15.1.5 Major News and Events
15.2 Company B
15.2.1 Business Overview
15.2.2 Products Offered
15.2.3 Business Strategies
15.2.4 SWOT Analysis
15.2.5 Major News and Events
15.3 Company C
15.3.1 Business Overview
15.3.2 Products Offered
15.3.3 Business Strategies
15.3.4 SWOT Analysis
15.3.5 Major News and Events
15.4 Company D
15.4.1 Business Overview
15.4.2 Products Offered
15.4.3 Business Strategies
15.4.4 SWOT Analysis
15.4.5 Major News and Events
15.5 Company E
15.5.1 Business Overview
15.5.2 Products Offered
15.5.3 Business Strategies
15.5.4 SWOT Analysis
15.5.5 Major News and Events
16 STRATEGIC RECOMMENDATIONS
17 APPENDIX
